Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kezar Life Sciences Inc | KZR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.84 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.84 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.6746 - 3.13 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.84 | USD |
Kezar Life Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 61.15M | 72.80M | - | 7M | -101.87M | -1.40 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kezar Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KZR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.83 | 0.8679 | 0.8011 | 0.8396473 | 553,375 | 0.01 | 1.20% |
| 1 Month | 0.8059 | 0.88 | 0.7701 | 0.8238313 | 590,403 | 0.0341 | 4.23% |
| 3 Months | 0.8356 | 1.135 | 0.7502 | 0.8992846 | 769,189 | 0.0044 | 0.53% |
| 6 Months | 0.8302 | 1.135 | 0.6746 | 0.8818711 | 725,289 | 0.0098 | 1.18% |
| 1 Year | 2.64 | 3.13 | 0.6746 | 1.40 | 667,190 | -1.80 | -68.18% |
| 3 Years | 5.56 | 18.55 | 0.6746 | 6.94 | 862,049 | -4.72 | -84.89% |
| 5 Years | 20.35 | 21.28 | 0.6746 | 6.72 | 624,484 | -19.51 | -95.87% |
Kezar Life Sciences Description
| Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program. |
